Publication | Closed Access
Olaratumab and doxorubicin versus doxorubicin alone for treatment of soft-tissue sarcoma: an open-label phase 1b and randomised phase 2 trial
582
Citations
13
References
2016
Year
Surgical OncologyOncologySoft-tissue SarcomaMetronomic TherapyPathologyOpen-label Phase 1BCancer TreatmentMedicineRadiation OncologyVersus Doxorubicin
| Year | Citations | |
|---|---|---|
Page 1
Page 1